IGF-1 gene-modified muscle-derived stem cells are resistant to oxidative stress via enhanced activation of IGF-1R/PI3K/AKT signaling and secretion of VEGF

Molecular and Cellular Biochemistry

Volumn 386, Issue 1-2, 2014, Pages 167-175

  Chen, Chunjing ^a   Xu, Ying ^b   Song, Yanfeng ^a,b  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b FUZHOU GENERAL HOSPITAL   (China)

Author keywords

IGF 1; IGF 1R PI3K AKT; Muscle derived stem cells; Oxidative stress; VEGF

Indexed keywords

1L 6 HYDROXYMETHYLCHIROINOSITOL 2 (2 O METHYL 3 O OCTADECYLCARBONATE); CARBONIC ACID DERIVATIVE; CASPASE 3; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PICROPODOPHYLLINB; PODOPHYLLIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PYRROLIDINE DITHIOCARBAMATE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; GENE OVEREXPRESSION; GENETICALLY ENGINEERED RAT STRAIN; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE DERIVED STEM CELL; NONHUMAN; OXIDATIVE STRESS; PARACRINE SIGNALING; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RAT; STEM CELL; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CASPASE 3; CULTURE MEDIA; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INSULIN-LIKE GROWTH FACTOR I; MUSCLE, SKELETAL; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84891519970     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1855-8     Document Type: Article

References (38)

1. Norton P, Brubaker L (2006) Urinary incontinence in women. Lancet 367:57-67
2. Milsom I, Ekelund P, Molander U, Arvidsson L, Areskoug B (1993) The influence of age, parity, oral contraception, hysterectomy and menopause on the prevalence of urinary incontinence in women. J Urol 149:1459-1462
3. Chabi B, Ljubicic V, Menzies KJ, Huang JH, Saleem A, Hood DA (2008) Mitochondrial function and apoptotic susceptibility in aging skeletal muscle. Aging Cell 7:2-12
4. McGuire EJ, Lytton B, Pepe V, Kohorn EI (1976) Stress urinary incontinence. Obstet Gynecol 47:255-264
5. Kevorkian R (2004) Physiology of incontinence. Clin Geriatr Med 20:409-425 v
6. Albo ME, Richter HE, Brubaker L, Norton P, Kraus SR, Zimmern PE, Chai TC, Zyczynski H, Diokno AC, Tennstedt S, Nager C, Lloyd LK, FitzGerald M, Lemack GE, Johnson HW, Leng W, Mallett V, Stoddard AM, Menefee S, Varner RE, Kenton K, Moalli P, Sirls L, Dandreo KJ, Kusek JW, Nyberg LM, Steers W (2007) Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med 356:2143-2155
7. Carr LK, Steele D, Steele S, Wagner D, Pruchnic R, Jankowski R, Erickson J, Huard J, Chancellor MB (2008) 1-Year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 19:881-883
8. Xu Y, Song YF, Lin ZX (2010) Transplantation of muscle-derived stem cells plus biodegradable fibrin glue restores the urethral sphincter in a pudendal nerve-transected rat model. Braz J Med Biol Res 43:1076-1083
9. Haider H, Ashraf M (2008) Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. J Mol Cell Cardiol 45:554-566
10. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE (2001) Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 33:907-921
11. Yanagiuchi A, Miyake H, Nomi M, Takenaka A, Fujisawa M (2009) Modulation of the microenvironment by growth factors regulates the in vivo growth of skeletal myoblasts. BJU Int 103:1569-1573
12. Kooijman R (2006) Regulation of apoptosis by insulin-like growth factor (IGF)-I. Cytokine Growth Factor Rev 17:305-323
13. Arthur PG, Grounds MD, Shavlakadze T (2008) Oxidative stress as a therapeutic target during muscle wasting: considering the complex interactions. Curr Opin Clin Nutr Metab Care 11:408-416
14. Marzetti E, Lees HA, Wohlgemuth SE, Leeuwenburgh C (2009) Sarcopenia of aging: underlying cellular mechanisms and protection by calorie restriction. BioFactors 35:28-35
15. Frasca F, Pandini G, Sciacca L, Pezzino V, Squatrito S, Belfiore A, Vigneri R (2008) The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem 114:23-37
16. Hao CN, Geng YJ, Li F, Yang T, Su DF, Duan JL, Li Y (2011) Insulin-like growth factor-1 receptor activation prevents hydrogen peroxide-induced oxidative stress, mitochondrial dysfunction and apoptosis. Apoptosis 16:1118-1127
17. Manning BD, Cantley LC (2007) AKT/PKB signaling: navigating downstream. Cell 129:1261-1274
18. Qu-Petersen Z, Deasy B, Jankowski R, Ikezawa M, Cummins J, Pruchnic R, Mytinger J, Cao B, Gates C, Wernig A, Huard J (2002) Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 157:851-864
19. Bamman MM, Shipp JR, Jiang J, Gower BA, Hunter GR, Goodman A, McLafferty CL Jr, Urban RJ (2001) Mechanical load increases muscle IGF-I and androgen receptor mRNA concentrations in humans. Am J Physiol Endocrinol Metab 280:E383-E390
20. Uchiyama T, Otani H, Okada T, Ninomiya H, Kido M, Imamura H, Nogi S, Kobayashi Y (2002) Nitric oxide induces caspase-dependent apoptosis and necrosis in neonatal rat cardiomyocytes. J Mol Cell Cardiol 34:1049-1061
21. Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132:344-362
22. Matheny RW Jr, Adamo ML (2009) Role of Akt isoforms in IGF-I-mediated signaling and survival in myoblasts. Biochem Biophys Res Commun 389:117-121
23. Sumino Y, Hanada M, Hirata Y, Sato F, Mimata H (2010) The effects of hepatocyte growth factor and insulin-like growth factor-1 on the myogenic differentiation of satellite cells in human urethral rhabdosphincter. Neurourol Urodyn 29:470-475
24. Hambrecht R, Schulze PC, Gielen S, Linke A, Mobius-Winkler S, Erbs S, Kratzsch J, Schubert A, Adams V, Schuler G (2005) Effects of exercise training on insulin-like growth factor-I expression in the skeletal muscle of non-cachectic patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 12:401-406
25. Isaeva EV, Shkryl VM, Shirokova N (2005) Mitochondrial redox state and Ca2+ sparks in permeabilized mammalian skeletal muscle. J Physiol 565:855-872
26. Negredo P, Rivero JL, Gonzalez B, Ramon-Cueto A, Manso R (2008) Slow- and fast-twitch rat hind limb skeletal muscle phenotypes 8 months after spinal cord transection and olfactory ensheathing glia transplantation. J Physiol 586:2593-2610
27. Yin M, Guan X, Liao Z, Wei Q (2009) Insulin-like growth factor-1 receptor-targeted therapy for non-small cell lung cancer: a mini review. Am J Transl Res 1:101-114
28. Piecewicz SM, Pandey A, Roy B, Xiang SH, Zetter BR, Sengupta S (2012) Insulin-like growth factors promote vasculogenesis in embryonic stem cells. PLoS ONE 7:e32191
29. Yee D (2002) The insulin-like growth factor system as a treatment target in breast cancer. Semin Oncol 29:86-95
30. Cook SA, Matsui T, Li L, Rosenzweig A (2002) Transcriptional effects of chronic Akt activation in the heart. J Biol Chem 277:22528-22533
31. Taguchi A, White MF (2008) Insulin-like signaling, nutrient homeostasis, and life span. Annu Rev Physiol 70:191-212
32. Samanta AK, Huang HJ, Bast RC Jr, Liao WS (2004) Overexpression of MEKK3 confers resistance to apoptosis through activation of NF-kappaB. J Biol Chem 279:7576-7583
33. Chong ZZ, Kang JQ, Maiese K (2003) Apaf-1, Bcl-xL, cytochrome c, and caspase-9 form the critical elements for cerebral vascular protection by erythropoietin. J Cereb Blood Flow Metab 23:320-330
34. Zhang M, Ling Y, Yang CY, Liu H, Wang R, Wu X, Ding K, Zhu F, Griffith BN, Mohammad RM, Wang S, Yang D (2007) A novel Bcl-2 small molecule inhibitor 4-(3-methoxy-phenylsulfannyl)-7-nitro-benzofurazan-3-oxide (MNB)-induced apoptosis in leukemia cells. Ann Hematol 86(7):471-481
35. Kang MH, Reynolds CP (2009) Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 15(4):1126-1132
36. Fulda S, Debatin KM (2006) Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25:4798-4811
37. Germani A, Di Carlo A, Mangoni A, Straino S, Giacinti C, Turrini P, Biglioli P, Capogrossi MC (2003) Vascular endothelial growth factor modulates skeletal myoblast function. Am J Pathol 163:1417-1428
38. Zhou L, Ma W, Yang Z, Zhang F, Lu L, Ding Z, Ding B, Ha T, Gao X, Li C (2005) VEGF165 and angiopoietin-1 decreased myocardium infarct size through phosphatidylinositol-3 kinase and Bcl-2 pathways. Gene Ther 12:196-202